The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Asymmetric Dimethylarginine, Blood Pressure, and Renal Perfusion in Elderly Subjects
Open accessAbstract
Background— Reduced availability of nitric oxide (NO) is thought to contribute to the age-associated increase of renovascular tone and blood pressure. We assessed blood concentrations of the endogenous NO synthase inhibitor asymmetric dimethylarginine (ADMA) as well as renal hemodynamics, comparing young (n=24, 13 men, 25±1 years) and elderly (n=24, 13 men, 69±2 years) healthy subjects and elderly subjects with essential hypertension (n=24, 13 men, 70±2 years). Methods and Results— Plasma ADMA concentration and renovascular resistance (RVR) were significantly higher ( P <0.05) and effective renal plasma flow (ERPF) significantly lower ( P <0.05) in elderly (2.77±0.20 μmol/L, 125±10 mm Hg/mL per minute, 487±26 mL/min per 1.73 m 2 ) than in young healthy subjects (1.30±0.11, 77±3, 654±18). Both ADMA levels and RVR were higher and ERPF lower in the hypertensive elderly subjects (3.53±0.23, 163±11, 427±19; P <0.05 versus both groups). In contrast, plasma concentrations of the biologically inactive stereoisomer symmetric dimethylarginine, l -arginine, and homocysteine were similar in the 3 groups studied. In the logistic regression analysis only ADMA was an independent determinant of both ERPF ( P <0.001; r 2 =0.80) and RVR ( P <0.002; r 2 =0.86). In addition, ADMA ( P <0.002) and serum glucose ( P <0.036) were independently related ( r 2 =0.67) to the level of blood pressure. Conclusions— These results are compatible with the notion that accumulation of the endogenous NO synthase inhibitor ADMA in senescent individuals is involved in the decrease of renal perfusion and increase of blood pressure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine
Valkonen, V.-P., Päivä, H., Salonen, J. T., Lakka, T. A., Lehtimäki, T., Laakso, J., & Laaksonen, R. (2001) · The Lancet · doi:10.1016/s0140-6736(01)07184-7 · Cited by 562
Cited by
Renal Aging: Causes and Consequences
O’Sullivan, E. D., Hughes, J., & Ferenbach, D. A. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015121308 · Cited by 484
Rochette, L., Lorin, J., Zeller, M., Guilland, J.-C., Lorgis, L., Cottin, Y., & Vergely, C. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.07.004 · Cited by 456
Kielstein, J. T., Impraim, B., Simmel, S., Bode-Böger, S. M., Tsikas, D., Frölich, J. C., Hoeper, M. M., Haller, H., & Fliser, D. (2004) · Circulation · doi:10.1161/01.cir.0000105764.22626.b1 · Cited by 401
Self-citationAsymmetrical Dimethylarginine: The Über Marker?
Cooke, J. P. (2004) · Circulation · doi:10.1161/01.cir.0000126823.07732.d5 · Cited by 396
Zhou, X. J., Rakheja, D., Yu, X., Saxena, R., Vaziri, N. D., & Silva, F. G. (2008) · Kidney International · doi:10.1038/ki.2008.319 · Cited by 396
Metadata
- Authors
- Kielstein, J. T., Bode-Böger, S. M., Frölich, J. C., Ritz, E., Haller, H., & Fliser, D.
- Venue
- Circulation
- Published
- 2003-04-15
- Volume
- 107
- Issue
- 14
- Pages
- 1891-1895
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2006197728
- Cited by
- 211
- References
- 1
- FWCI
- 10.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Asymmetric Dimethylarginine, Blood Pressure, and Renal Perfusion in Elderly Subjects. https://app.cochat.ai/papers/10.1161/01.cir.0000060496.23144.a7
- The paper
- Kielstein, J. T., Bode-Böger, S. M., Frölich, J. C., Ritz, E., Haller, H., & Fliser, D. (2003). Asymmetric Dimethylarginine, Blood Pressure, and Renal Perfusion in Elderly Subjects. Circulation. https://doi.org/10.1161/01.cir.0000060496.23144.a7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.